Posted in | News | Optics and Photonics

New Market Research Report on Global and Chinese Optical Film Industry

Research and Markets has announced the addition of the "Global and Chinese Optical Film Industry Report, 2012" report to their offering.

Optical film covers 3 categories: polarizer, optical film for BLU, and ITO film for touch screen. The total market scale is about USD 11.194 billion in 2012, among which, the polarizer market scales about USD 7.728 billion, down 2% from last year.

Polarizer market shows very high concentration and stability, and top six major players occupy above 96% of the market. The key for polarizer business lies in the supply of raw materials, mainly including TAC and PVA. TAC, also as a main material of film, is monopolized by Fujifilm and Konica Minolta, with market share of about 72% and 26% respectively.

The market scale of optical film for BLU is about USD 2.938 billion in 2012, down 9.9% from 2011, mainly due to the drastic decline of DBEF sector. Optical film generally covers 6 categories:

  1. Reflective Film, Reflector
  2. Diffuser Film
  3. Normal Prism
  4. Multi-Function Prism
  5. Micro Lens Film
  6. Reflective Polarizer, Dual Brightness Enhancement Film (DBEF)

ITO film is mainly applied to touch screens. GFF and G1F touch screens need to use ITO film. The market growth rate hits 20% in 2012. GG, INCELL and ONCELL touch screens occupy the high-end market, but GFF and G1F touch screens, being cheaper and slightly thinner, though less transparent, occupy the mid and low-end market. Moreover, tablet PCs under 10-inch prefer G1F touch screens, such as Samsung Galaxy Tab and newest Apple iPad Mini. Japan's Nitto Denko has monopolized the market of ITO film for capacitive touch screen.

Source: http://www.researchandmarkets.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.